Transfection Reagents and Equipment Market Size and Forecast (2020-2030)
Transfection Reagents and Equipment Market Size and Forecast (2020 – 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Reagents and Instruments), Method (Viral Methods, Non Viral Methods, and Hybrid Methods), Application (Biomedical Research, Protein Production, and Therapeutic Delivery), End User (Academics & Research Institutes and Pharmaceutical & Biotechnology Companies), and Geography
$3,633 – $6,433
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Growing Economic Burden of Cancer is Driving the Transfection Reagents and Equipment Market Growth
According to the World Health Organization (WHO), cancer is one of the leading causes of death worldwide, and it accounted for ~10 million deaths in 2020. As per the International Agency for Research on Cancer, the global cancer burden is likely to increase with the addition of 30.2 million more cases by 2040. According to the Breast Cancer Organization, approximately 5–10% of breast cancer cases worldwide are hereditary and are caused by abnormal genes passed from generations. According to the article “Lifestyle, Genetic Risk and Incidence of Cancer,” published in the International Journal of Epidemiology in 2023, nearly 33% of cancer conditions that occur are hereditary, and the risk of genetic mutations is high in the disease. Hence, people opt for genetic profiling for the early detection and personalized treatment of hereditary cancer cases. BRCA1 and BRCA2 are sometimes referred to as tumor suppressor genes. People who inherit the harmful variants of one of these genes are at a greater risk of several cancers, most notably breast and ovarian cancer, among other types. These people also tend to develop cancer at younger ages compared to people who do not have variations in the said genes. Studies focused on nucleic acid processing by cancer cells will likely help understand cancer metabolism. DNA is typically packaged into a viral or non-viral particle to be transferred into the cell to be transfected. Gene transfer has been proposed as a new approach to enhance the effectiveness of antitumor drugs in treating intractable or metastatic cancers. The association of gene therapy and drugs (similar therapy) has been reported to strengthen the antiproliferative effects of classical treatments in lung, colorectal, pancreatic, bladder, and breast cancers, among others. Thus, the elevating economic burden of cancer bolsters the transfection reagents and equipment market.
Cell and gene therapy manufacturing is a complicated process, which makes its execution and monitoring critical. Advancements in biotechnology have led to the adoption of personalized treatments for the treatment of numerous indications. Cell and gene therapies are mostly used to treat chronic diseases such as neurological disorders, cancer, and genetic disorders. The noteworthy advantages of cell and gene therapy include targeted treatment, faster and more efficient recovery, and reduced side effects. Cell and gene therapies are widely adopted worldwide owing to the availability of Food and Drug Administration (FDA) approved products. For instance, the FDA approved an adenovirus, ADSTILADRIN manufactured by Ferring Pharmaceuticals A/S in 2022. This recombinant adenovirus (rAd-IFNa/Syn3) delivers human interferon alfa-2b cDNA into the bladder epithelium to treat patients suffering from certain types of bladder cancer. In 2022, CARVYKTI, manufactured by Janssen Biotech, Inc., was also approved by the FDA. CARVYKTI is an autologous CAR-T cell engineered with lentivirus to attack BCMA-expressing tumor cells to treat certain kinds of relapsed or refractory multiple myeloma.
According to the article “Gene therapy process change evaluation framework: Transient transfection and stable producer cell line comparison,” published by the University College London (UCL) in 2020, 423 ongoing clinical trials were being conducted to test gene therapy products. Scientists nowadays employ the transfection technique for the production of these therapies. Hence, an upsurge in the popularity of cell and gene therapy activities fuels the number of transfection procedures performed, which, in turn, fuels the growth of the transfection reagents and equipment market.
The transfection reagents and equipment market is divided based on product, modality, application, end user, and geography. Based on product, the market is classified into reagents and equipment. Based on modality, the transfection reagents and equipment market is classified into viral, non-viral, and hybrid methods. In terms of application, the transfection reagents and equipment market is classified into biomedical research, protein production, and therapeutic delivery. The transfection reagents and equipment market, by end-user, is classified into academic and research institutes and pharmaceutical and biotechnological companies.
The market is segmented based on geography into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. North America is the largest contributor to the global transfection reagents and equipment market growth. Asia Pacific is expected to register the highest CAGR in the transfection reagents and equipment market from 2022 to 2030. Cell and gene therapies (CGTs) are prescribed to treat patients suffering from serious and rare diseases with unaddressed therapeutic needs. Manufacturing CGTs is a highly complex process, with insufficient infrastructure and expertise being a major limiting factor. Logistics-related challenges associated with intermediates and final products limit companies’ CGT manufacturing capacity. The CGT manufacturing process involves extracting autologous cells through “apheresis,” dispatching them to specialized laboratories, and sending them back to clinics for patient administration, all of which must be performed with strict quality control. The US Food and Drug Administration (FDA) has approved only 7 CGT drugs so far, and the pipeline of new products has reached ~1,200 experimental therapies. Half of these are in Phase 2 clinical trials. With these prospects, annual sales of cell and gene therapies are estimated to grow by 15% and ~30%, respectively, as stated in the Chemical & Engineering News Report 2023. Many manufacturers approach contract development manufacturing organizations (CDMOs) such as Labcorp, Lonza, and Catalent to overcome the barriers associated with the production and commercialization of their CGT products. Lonza has invested ~US$ 9.2 million to strengthen its cell and gene therapy manufacturing capabilities. Such initiatives by CDMOs are contributing to the growth of the transfection reagents and equipment market in the US.
ClinicalTrails.com, Centers for Disease Control and Prevention (CDC), World Health Organization (WHO), and Food and Drug Administration (FDA) are a few key primary and secondary sources referred to while preparing the report on the transfection reagents and equipment market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Publishing status: | |
| Geographical coverage: | |
| Year of Publication: |
According to our latest study on “Transfection Reagents and Equipment Market Forecast to 2030 –Global Analysis – Modality, Product, Application and End User,” the market is expected to grow from US$ 1.170 billion in 2022 and is expected to reach US$ 2.145 billion by 2030; it is anticipated to record a CAGR of 7.8% from 2022 to 2030. The report highlights the key factors driving the transfection reagents and equipment market growth and prominent players with their developments in the market.
The expansion of the transfection reagents and equipment market size is attributed to the rising cases of chronic diseases and the surging popularity of cell and gene therapy. Transfection is the process of transferring foreign particles and nucleic acids into cells through chemical, physical, and biological means. Transfection reagents are used to improve the efficacy of genetic experiments performed as a part of substantial research conducted in applied gene therapies. In all transfection experiments, the methods by which compounds are delivered into cells must be carefully chosen. Viral-mediated transfection has demonstrated considerable effectiveness, and the transfected products can induce significant immune responses. However, chemical alternatives have been developed to curb the ill effects associated with the use of viruses in the technique.
Transfection is the complex step in developing a viral vector, including adenovirus, adeno-associated virus, and lentivirus. Transient transfection must also be ramped up as the manufacturing processes are scaled up. Process equipment vendors, drug developers, and raw material suppliers are focusing on collaborations to develop cost-effective, practical, and platformizable solutions for rapidly developing and scaling up viral vector manufacturing processes. With planned material volumes and transfer & mixing times, transfecting cells with multiple plasmids becomes feasible on small scales. Scaling up requires experience in industrializing the transfection step since most companies only have transfection experience at the lab level. However, the volume of cell-culture media and transfection reagents required for scaling up the process to a larger level can be impractical, emphasizing the need for optimization.
Nonetheless, broadening the production scale has become common in recent years with the surging demand for viral vectors. With numerous challenges associated with large-scale transfection processes, the best approach to increase production is reducing the process rather than scaling up the process. This top-down approach allows clear identification of the conditions that will impact the process at the industrial level, such as the volume of transfection complex solution. This approach also facilitates process optimization and decision-making. Developing such approaches to ramp up the small-scale transfection processes is an opportunity to grow the transfection reagents and equipment market.
The transfection reagents and equipment market is segmented by application into biomedical research, protein production, and therapeutic delivery. In 2022, the biomedical research segment held the largest share of the market. Moreover, the same segment is expected to grow at the fastest CAGR from 2022 to 2030. Transfection has emerged as a crucial biomedical research technique due to its ability to manipulate gene expression. Gene transfer has been proposed as a new approach to enhance the effectiveness of anti-tumor drugs in treating intractable or metastatic cancers. The association of gene therapy and drugs (similar therapy) has been reported to increase the antiproliferative effects of classic colorectal, lung, pancreatic, bladder, and breast cancer treatments, among others. Cultivated mammalian cells have become a dominant medium for manufacturing recombinant proteins for clinical applications due to their ability to aid proper protein folding, assembly, and posttranslational modifications. Genetically engineered mammalian cell lines generally secrete biotherapeutics into their culture medium, and they can then be purified to homogeneity and sterilized under well-defined regulated conditions. The development of a process for manufacturing recombinant proteins in mammalian cells follows a well-established process that starts with transferring a recombinant gene with the necessary transcriptional regulatory elements to the cells by transfection. Nucleic acid-based therapeutics such as using messenger RNA (mRNA) as a drug molecule have immense potential in treating chronic diseases, including age-related neurodegenerative diseases. Currently, gene therapies such as siRNA, shRNA, CRISPR/Cas9 system, plasmid DNA, antisense oligonucleotide, and miRNA have shown great potential in biomedical applications. Developing sophisticated drug delivery vehicles is of utmost importance to avoid the degradation of gene therapy components in the body, facilitating their effective delivery to target tissues, cells, and organelles. Viral vectors are the most widely used delivery vehicles for in vivo and in vitro gene therapies due to their high transfection efficiency and stable transgene expression.
Thermo Fisher Scientific Inc., Promega Corporation, Qiagen N.V., Merck KGaA, Lonza Group, F.Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc., Mirus Bio LLC, MaxCyte Inc, and Polyplus-Transfection SA are among the leading companies operating in the global transfection reagents and equipment market.
Companies operating in the transfection reagents and equipment market adopt various organic and inorganic strategies. Organic strategies mainly include product launches and product approvals. Acquisitions, collaborations, and partnerships are among the inorganic growth strategies witnessed in the transfection reagents and equipment market. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, thereby contributing to transfection reagents and equipment growth. Further, acquisition and partnership strategies help them strengthen their customer base and expand their product portfolios.
A few of the significant developments by key market players are listed below.
• In August 2023, Mirus Bio launched the RevIT AAV Enhancer. When added to the adeno-associated virus (AAV) production process, the novel enhancer increases AAV titers 2–4 times in suspension 293 cells. It can be combined with Mirus Bio’s VirusGEN transfection platform and with polymer-only transfection reagents with minimal process optimization. As evidence of its broad applicability, the RevIT Enhancer has been used to increase titers in all AAV serotypes tested to date, with various cell lines and cell culture media commonly used to produce recombinant AAV.
o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the transfection reagents and equipment market.
o Highlights key business priorities to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the transfection reagents and equipment, allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans using substantial growth offerings in developed and emerging markets.
o Scrutinize in-depth market trends and outlook coupled with the factors driving the transfection reagents and equipment market and those hindering it.
o Enhance the decision-making process by understanding the strategies underpinning security interest concerning client products, segmentation, pricing, and distribution.
TABLE OF CONTENTS<div class="twocol"
LIST OF TABLES
Table 1. Transfection Reagents and Equipment Market Segmentation
Table 2. Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Table 3. Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million) – by Product
Table 4. Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million) – by Modality
Table 5. Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million) – by Viral
Table 6. Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million) – by Non-Viral
Table 7. Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million) – by Physical/mechanical Method
Table 8. Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million) – by Chemical Method
Table 9. Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million) – by Application
Table 10. Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million) – by End Users
Table 11. North America: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 12. North America: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Modality
Table 13. North America: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Viral
Table 14. North America: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Non-Viral
Table 15. North America: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Physical/mechanical Method
Table 16. North America: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Chemical Method
Table 17. North America: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 18. North America: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by End Users
Table 19. North America: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Country
Table 20. United States: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 21. United States: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Modality
Table 22. United States: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Viral
Table 23. United States: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Non-Viral
Table 24. United States: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Physical/mechanical Method
Table 25. United States: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Chemical Method
Table 26. United States: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 27. United States: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by End Users
Table 28. Canada: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 29. Canada: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Modality
Table 30. Canada: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Viral
Table 31. Canada: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Non-Viral
Table 32. Canada: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Physical/mechanical Method
Table 33. Canada: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Chemical Method
Table 34. Canada: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 35. Canada: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by End Users
Table 36. Mexico: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 37. Mexico: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Modality
Table 38. Mexico: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Viral
Table 39. Mexico: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Non-Viral
Table 40. Mexico: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Physical/mechanical Method
Table 41. Mexico: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Chemical Method
Table 42. Mexico: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 43. Mexico: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by End Users
Table 44. Europe: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 45. Europe: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Modality
Table 46. Europe: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Viral
Table 47. Europe: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Non-Viral
Table 48. Europe: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Physical/mechanical Method
Table 49. Europe: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Chemical Method
Table 50. Europe: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 51. Europe: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by End Users
Table 52. Europe: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Country
Table 53. United Kingdom: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 54. United Kingdom: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Modality
Table 55. United Kingdom: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Viral
Table 56. United Kingdom: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Non-Viral
Table 57. United Kingdom: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Physical/mechanical Method
Table 58. United Kingdom: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Chemical Method
Table 59. United Kingdom: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 60. United Kingdom: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by End Users
Table 61. Germany: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 62. Germany: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Modality
Table 63. Germany: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Viral
Table 64. Germany: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Non-Viral
Table 65. Germany: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Physical/mechanical Method
Table 66. Germany: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Chemical Method
Table 67. Germany: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 68. Germany: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by End Users
Table 69. France: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 70. France: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Modality
Table 71. France: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Viral
Table 72. France: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Non-Viral
Table 73. France: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Physical/mechanical Method
Table 74. France: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Chemical Method
Table 75. France: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 76. France: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by End Users
Table 77. Italy: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 78. Italy: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Modality
Table 79. Italy: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Viral
Table 80. Italy: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Non-Viral
Table 81. Italy: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Physical/mechanical Method
Table 82. Italy: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Chemical Method
Table 83. Italy: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 84. Italy: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by End Users
Table 85. Spain: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 86. Spain: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Modality
Table 87. Spain: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Viral
Table 88. Spain: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Non-Viral
Table 89. Spain: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Physical/mechanical Method
Table 90. Spain: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Chemical Method
Table 91. Spain: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 92. Spain: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by End Users
Table 93. Rest of Europe: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 94. Rest of Europe: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Modality
Table 95. Rest of Europe: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Viral
Table 96. Rest of Europe: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Non-Viral
Table 97. Rest of Europe: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Physical/mechanical Method
Table 98. Rest of Europe: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Chemical Method
Table 99. Rest of Europe: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 100. Rest of Europe: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by End Users
Table 101. Asia Pacific: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 102. Asia Pacific: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Modality
Table 103. Asia Pacific: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Viral
Table 104. Asia Pacific: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Non-Viral
Table 105. Asia Pacific: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Physical/mechanical Method
Table 106. Asia Pacific: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Chemical Method
Table 107. Asia Pacific: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 108. Asia Pacific: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by End Users
Table 109. Asia Pacific: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Country
Table 110. China: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 111. China: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Modality
Table 112. China: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Viral
Table 113. China: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Non-Viral
Table 114. China: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Physical/mechanical Method
Table 115. China: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Chemical Method
Table 116. China: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 117. China: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by End Users
Table 118. Japan: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 119. Japan: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Modality
Table 120. Japan: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Viral
Table 121. Japan: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Non-Viral
Table 122. Japan: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Physical/mechanical Method
Table 123. Japan: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Chemical Method
Table 124. Japan: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 125. Japan: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by End Users
Table 126. India: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 127. India: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Modality
Table 128. India: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Viral
Table 129. India: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Non-Viral
Table 130. India: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Physical/mechanical Method
Table 131. India: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Chemical Method
Table 132. India: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 133. India: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by End Users
Table 134. South Korea: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 135. South Korea: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Modality
Table 136. South Korea: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Viral
Table 137. South Korea: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Non-Viral
Table 138. South Korea: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Physical/mechanical Method
Table 139. South Korea: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Chemical Method
Table 140. South Korea: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 141. South Korea: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by End Users
Table 142. Australia: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 143. Australia: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Modality
Table 144. Australia: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Viral
Table 145. Australia: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Non-Viral
Table 146. Australia: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Physical/mechanical Method
Table 147. Australia: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Chemical Method
Table 148. Australia: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 149. Australia: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by End Users
Table 150. Rest of APAC: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 151. Rest of APAC: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Modality
Table 152. Rest of APAC: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Viral
Table 153. Rest of APAC: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Non-Viral
Table 154. Rest of APAC: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Physical/mechanical Method
Table 155. Rest of APAC: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Chemical Method
Table 156. Rest of APAC: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 157. Rest of APAC: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by End Users
Table 158. Middle East and Africa: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 159. Middle East and Africa: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Modality
Table 160. Middle East and Africa: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Viral
Table 161. Middle East and Africa: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Non-Viral
Table 162. Middle East and Africa: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Physical/mechanical Method
Table 163. Middle East and Africa: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Chemical Method
Table 164. Middle East and Africa: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 165. Middle East and Africa: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by End Users
Table 166. Middle East and Africa: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Country
Table 167. Saudi Arabia: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 168. Saudi Arabia: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Modality
Table 169. Saudi Arabia: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Viral
Table 170. Saudi Arabia: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Non-Viral
Table 171. Saudi Arabia: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Physical/mechanical Method
Table 172. Saudi Arabia: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Chemical Method
Table 173. Saudi Arabia: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 174. Saudi Arabia: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by End Users
Table 175. South Africa: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 176. South Africa: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Modality
Table 177. South Africa: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Viral
Table 178. South Africa: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Non-Viral
Table 179. South Africa: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Physical/mechanical Method
Table 180. South Africa: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Chemical Method
Table 181. South Africa: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 182. South Africa: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by End Users
Table 183. United Arab Emirates: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 184. United Arab Emirates: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Modality
Table 185. United Arab Emirates: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Viral
Table 186. United Arab Emirates: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Non-Viral
Table 187. United Arab Emirates: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Physical/mechanical Method
Table 188. United Arab Emirates: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Chemical Method
Table 189. United Arab Emirates: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 190. United Arab Emirates: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by End Users
Table 191. Rest of Middle East and Africa: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 192. Rest of Middle East and Africa: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Modality
Table 193. Rest of Middle East and Africa: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Viral
Table 194. Rest of Middle East and Africa: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Non-Viral
Table 195. Rest of Middle East and Africa: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Physical/mechanical Method
Table 196. Rest of Middle East and Africa: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Chemical Method
Table 197. Rest of Middle East and Africa: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 198. Rest of Middle East and Africa: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by End Users
Table 199. South and Central America: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 200. South and Central America: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Modality
Table 201. South and Central America: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Viral
Table 202. South and Central America: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Non-Viral
Table 203. South and Central America: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Physical/mechanical Method
Table 204. South and Central America: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Chemical Method
Table 205. South and Central America: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 206. South and Central America: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by End Users
Table 207. South and Central America: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Country
Table 208. Brazil: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 209. Brazil: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Modality
Table 210. Brazil: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Viral
Table 211. Brazil: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Non-Viral
Table 212. Brazil: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Physical/mechanical Method
Table 213. Brazil: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Chemical Method
Table 214. Brazil: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 215. Brazil: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by End Users
Table 216. Argentina: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 217. Argentina: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Modality
Table 218. Argentina: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Viral
Table 219. Argentina: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Non-Viral
Table 220. Argentina: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Physical/mechanical Method
Table 221. Argentina: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Chemical Method
Table 222. Argentina: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 223. Argentina: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by End Users
Table 224. Rest of South and Central America: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 225. Rest of South and Central America: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Modality
Table 226. Rest of South and Central America: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Viral
Table 227. Rest of South and Central America: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Non-Viral
Table 228. Rest of South and Central America: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Physical/mechanical Method
Table 229. Rest of South and Central America: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Chemical Method
Table 230. Rest of South and Central America: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 231. Rest of South and Central America: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by End Users
Table 232. Recent Inorganic Growth Strategies in the Transfection Reagents and Equipment Market
Table 233. Recent Organic Growth Strategies in The Transfection Reagents and Equipment Market
Table 234. Glossary of Terms, Deep Brain Simulation Market
LIST OF FIGURES
Figure 1. Transfection Reagents and Equipment Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Transfection Reagents and Equipment Market Revenue (US$ Million), 2022–2030
Figure 5. Transfection Reagents and Equipment Market Share (%) – by Product (2022 and 2030)
Figure 6. Reagents: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Equipment: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Transfection Reagents and Equipment Market Share (%) – by Modality (2022 and 2030)
Figure 9. Viral: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Retrovirus: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Adenovirus: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Adeno-Associated Virus: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Herpes Virus: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Non-Viral: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Physical/Mechanical: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Electroporation: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Microinjection: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Biolistic Method: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Laser Method: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Magnetofection: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Sonoporation: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Chemical Method: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Liposomal Based/High Lipid: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. Non-Liposomal Based/High Lipid: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. Hybrid: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 26. Transfection Reagents and Equipment Market Share (%) – by Application (2022 and 2030)
Figure 27. Biomedical Research: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 28. Protein Production: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 29. Therapeutic Delivery: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 30. Transfection Reagents and Equipment Market Share (%) – by End Users (2022 and 2030)
Figure 31. Academic and Research Institutes: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 32. Pharmaceutical and Biotechnological Companies: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 33. Transfection Reagents and Equipment Market Breakdown by Region, 2022 and 2030 (%)
Figure 34. North America: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million)
Figure 35. North America: Transfection Reagents and Equipment Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 36. United States: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million)
Figure 37. Canada: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million)
Figure 38. Mexico: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million)
Figure 39. Europe: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million)
Figure 40. Europe: Transfection Reagents and Equipment Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 41. United Kingdom: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million)
Figure 42. Germany: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million)
Figure 43. France: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million)
Figure 44. Italy: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million)
Figure 45. Spain: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million)
Figure 46. Rest of Europe: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million)
Figure 47. Asia Pacific: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million)
Figure 48. Asia Pacific: Transfection Reagents and Equipment Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 49. China: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million)
Figure 50. Japan: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million)
Figure 51. India: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million)
Figure 52. South Korea: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million)
Figure 53. Australia: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million)
Figure 54. Rest of APAC: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million)
Figure 55. Middle East and Africa: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million)
Figure 56. Middle East and Africa: Transfection Reagents and Equipment Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 57. Saudi Arabia: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million)
Figure 58. South Africa: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million)
Figure 59. United Arab Emirates: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million)
Figure 60. Rest of Middle East and Africa: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million)
Figure 61. South and Central America: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million)
Figure 62. South and Central America: Transfection Reagents and Equipment Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 63. Brazil: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million)
Figure 64. Argentina: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million)
Figure 65. Rest of South and Central America: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million)
Figure 66. Growth Strategies in The Transfection Reagents and Equipment Market, 2020-2023
The List of Companies – Transfection Reagents And Equipment Market
o Thermo Fisher Scientific Inc.
o Promega Corporation
o Qiagen N.V.
o Merck KGaA
o Lonza Group
o F.Hoffmann-La Roche Ltd
o Bio-Rad Laboratories Inc.
o Mirus Bio LLC
o MaxCyte Inc
o Polyplus-Transfection SA.
You must be logged in to post a review.
Reviews
There are no reviews yet.